Fuan Pharmaceutical (300194.SZ): "Cefuroxime axetil granules" obtain drug registration certificate.

Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. ("Qingyutang") recently received a drug registration certificate issued by the National Medical Products Administration for the drug "Cefaloridine Granules". Cefaloridine Granules are used for secondary infections caused by sensitive bacteria, such as superficial skin infections, deep skin infections, lymphangitis and lymphadenitis, chronic purulent dermatitis, secondary infections of wounds, burns, surgical incisions, perianal abscesses, pharyngitis and laryngitis, tonsillitis, acute bronchitis, pneumonia, lung abscess, secondary infections of chronic respiratory diseases, otitis media, sinusitis, periodontitis, osteomyelitis, cystitis, pyelonephritis, scarlet fever, and whooping cough. According to the National Medical Products Administration's data query platform, as of now, there are a total of 2 companies (including Qingyutang) that have passed consistency evaluation or been deemed to pass consistency evaluation for this drug.